Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis
Authors:
- 1 August 2024
- journal article
- research article
- Vol. 39 (8) , 1025-1035
Abstract
Objective. The aim of this study was to find novel biomarkers and develop a non-invasive, effective diagnostic model for hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis. Method. Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to assess the expression of differentially expressed genes ( AGRN , JAG], , CCL5, , ID3, , CCND], , and CAPN2) ) in peripheral blood mononuclear cells (PBMCs) from healthy subjects, chronic hepatitis B (CHB), and liver fibrosis/cirrhosis (LF/LC) patients. The molecular mechanisms underlying AGRN-regulated CHB were further explored and verified in LX2 cells, in which small interfering RNA (siRNA) was used to block AGRN gene expression. Finally, enzyme-linked Immunosorbent Assay (ELISA) was used to measure AGRN protein expression in 100 healthy volunteers, 100 CHB patients, and 100 LF/LC patients, and the efficacy of the diagnostic model was assessed by the Area Under the Curve (AUC). Results. AGRN mRNA displayed a steady rise in the PBMCs of normal, CHB, and LF/LC patients. Besides, AGRN expression was markedly elevated in activated LX2 cells, whereas the expression of COL1 and alpha-SMA decreased when AGRN was inhibited using siRNA. In addition, downregulation of AGRN can reduce the gene expression of (3-catenin and c-MYC while upregulating the expression of GSK-3(3. Furthermore, PLT and AGRN were used to develop a non-invasive diagnostic model (PA). To identify CHB patients from healthy subjects, the AUC of the PA model was 0.951, with a sensitivity of 87.0% and a specificity of 91.0%. The AUC of the PA model was 0.922 with a sensitivity of 82.0% and a specificity of 90.0% when differentiating between LF/LC and CHB patients. Conclusion. The current study indicated that AGRN could be a potential plasma biomarker and the established PA model could improve the diagnostic accuracy for HBV-related liver diseases.Keywords
This publication has 41 references indexed in Scilit:
- Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysisHepatology, 2014
- Crosstalk between Agrin and Wnt signaling pathways in development of vertebrate neuromuscular junctionDevelopmental Neurobiology, 2014
- Magnetic resonance elastography of liver: Technique, analysis, and clinical applicationsJournal of Magnetic Resonance Imaging, 2013
- Structural mechanisms of the agrin–LRP4–MuSK signaling pathway in neuromuscular junction differentiationCellular and Molecular Life Sciences, 2012
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- E-cadherin, β-catenin, and ZEB1 in malignant progression of cancerCancer and Metastasis Reviews, 2009
- Chronic hepatitis BHepatology, 2007
- Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferationHepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001